[Our experience with the use of a new mucolytic agent in therapy of respiratory insufficiency].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001927:Brain Diseases / Q000150:complications; D001987:Bronchiectasis / Q000150:complications; D001991:Bronchitis / Q000150:complications; D001996:Bronchopneumonia / Q000150:complications; D002648:Child; D002675:Child, Preschool; D003510:Cyclohexanes / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007223:Infant; D008169:Lung Abscess / Q000150:complications; D008297:Male; D008875:Middle Aged; D011041:Poisoning / Q000150:complications; D011654:Pulmonary Edema / Q000150:complications; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D012131:Respiratory Insufficiency / Q000188:drug therapy* / Q000209:etiology; D013742:Tetanus / Q000150:complications; D013898:Thoracic Injuries / Q000150:complications; D014050:Toluene / Q000627:therapeutic use*
D003510:Cyclohexanes; D000644:Quaternary Ammonium Compounds; D014050:Toluene
La nostra esperienza sull'impiego di un nuovo mucolitico nella terapia delle insufficienze respiratorie.